BVS
Bioventus Inc. · Healthcare
Chief Commercial Officer John Nosenzo sold $734K of Bioventus Inc.
Sold$733,502
$11.12Price
65,963Shares
−44%Stake
What BVS did after the filing
- The stock from Wed, Apr 6 open, $13.74
- −37.0%
- S&P 500, same days
- −12.9%
Measured over 30 trading days, to the May 19 close.
Traded Mon, Apr 4. Filed Tue, Apr 5, 5:14 PM ET, after the close. Returns use the Apr 6 open and the May 19 close. Not investment advice.